ORCHA is the world’s leading, independent digital health evaluation and distribution organization. It recently partnered with American Telemedicine Association (ATA) to help give patients access to safe and effective health apps. ORCHA has evaluated more than 4,000 health apps currently available in the U.S. against its criteria and found only 15% meet quality thresholds. Most apps fail to meet healthcare, security or usability standards established to safeguard patients.1
In its latest report, ORCHA conducted an assessment on 3,206 apps worldwide that support individuals with cancer available in the app stores. It found that only 24.7% met minimum quality thresholds.
Digital health apps were measured against 350 criteria, including reliability, relevance, usability, and clinical validation. In the report, ORCHA highlights five apps – including Untire that achieve an excellent score on all the criteria tested. These findings are available in the ORCHA Cancer Services Report.
Bram Kuiper, PhD, co-founder of Untire and clinical psycho-oncologist stated, “In this time of the COVID pandemic, it’s important that safe, proven digital therapeutics like Untire are made available to support cancer patients wherever they are: in the hospital, doctor’s office or at home.”
#1 Cancer Side Effect
Fatigue is the most common and debilitating side effect of cancer and its treatments. It often impacts daily living with devastating effects on an individual’s physical, social, psychological, and cognitive functioning. Today, more than 16.9 million cancer survivors in the US, according to the American Cancer Society. 80% of all individuals with cancer are severely fatigued the first year of treatment with one in three individuals experiencing long- term fatigue.
Global Digital Therapeutic
Untire is based on a combination of proven psychological methods including Cognitive Behavior Therapy (CBT), Mindfulness-based Cognitive Therapy (MBCT) with Physical and Psychological Rehabilitation. The program consists of ongoing energy measurement combined with education, stress-reducing mindfulness activities, and physical exercises with video and audio guides.
With Untire, cancer patients and survivors reported a significant reduction in fatigue severity, fatigue interference, and improvement in overall quality of life significantly improved in over 12 weeks.2
Today, Untire supports over 30,000 individuals in over 20 countries including the UK, USA, Canada, and Australia.
Tired of Cancer, the company behind Untire, is in talks with insurers and healthcare providers in several countries including the UK and USA to make Untire a reimbursed digital treatment for cancer fatigue.
 American Telemedicine Association partners with ORCHA to launch review process in the U.S. – ORCHA (orchahealth.com)
 ‘Beating Cancer-Related Fatigue with the ‘Untire’ Mobile App: Results from a Waiting-List Randomized Controlled Trial’ The Journal of Psycho-Oncology https://onlinelibrary.wiley.com/doi/abs/10.1002/pon.5492